Project Grant R21AI185486
Award Date
4/15/25
Completion Date
3/31/27
Dollars Obligated
$205K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
This $1,444,195 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to discover strategies to enhance the activity of topoisomerase inhibitors against antibiotic-resistant Escherichia coli and Pseudomonas aeruginosa pathogens. The key objectives are to: 1) identify metabolites that can modulate persistence and resistance development in these bacteria toward...
This federal Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), will enable research to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The $462,500 award, with a period of performance from January 1, 2025 to November 30, 2029, will support the long-term goal of comprehensively characterizing bacterial...
This federal Project Grant award of $661,387 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports comprehensive research into the regulation and mechanisms of antibiotic resistance mediated by RND efflux pumps in the pathogenic bacterium Pseudomonas aeruginosa. The research program, conducted by Emory University in collaboration with the University of Texas at Austin, aims to uncover novel physiological aspects and the...
This Project Grant award of $1,148,000.00 from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) aims to develop novel approaches for combating bacterial infections and antibiotic resistance. The principal investigator at Princeton University will leverage single-cell RNA sequencing techniques, including the M3-SEQ and Dual-M3-SEQ methods, to gain unprecedented insights into host-pathogen interactions and phage dynamics. This knowledge will then inform the...
The federal Project Grant award R44AI184155, valued at $1,999,996.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports Curza Inc., a for-profit biotechnology company, in developing a new class of broad-spectrum antibiotics targeting multidrug-resistant Gram-negative pathogens. The key objectives of the project include optimizing lead antibiotic compounds, conducting...
This Project Grant award, totaling $430,354, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research into the molecular mechanisms that contribute to the clinical dominance of Pseudomonas aeruginosa sequence type 111 (ST111) isolates, a highly antibiotic-resistant strain that frequently causes healthcare-associated infections in immunocompromised patients. The key...
The federal Project Grant award R21AI190788, totaling $256,995.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to develop a generalizable strategy to quantitatively link bacterial pathogen traits, such as fitness and iron starvation response, to host cell mutations using optical sequencing techniques. The goal is to better understand how intravacuolar pathogens, like...
This federal Project Grant award, valued at $453,900.00 and granted by the National Institute of Allergy and Infectious Diseases (NIAID), supports research to develop a universal bacterial genome editing platform using broad-specificity phage recombinases. The project aims to overcome the limitations of current genetic engineering tools, which are typically restricted to laboratory-adapted bacterial strains, by leveraging conserved phage proteins to enable genetic manipulation across a wide...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $868,776 to Boston Children's Hospital to characterize the regulatory functions of a novel post-transcriptional regulator called PHAF in the opportunistic pathogen Pseudomonas aeruginosa. The research aims to identify PHAF's direct regulatory targets, investigate its role in virulence and biofilm formation, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $749,417 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to President and Fellows of Harvard College. The funding will support research focused on developing novel bactericidal antibiotics to address the growing threat of multi-drug resistant pathogens, such as Escherichia coli and Klebsiella pneumoniae. The research aims to synthesize and biologically evaluate a modular platform of...